ArticleDiabetes & metabolism journal2024
Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64).
Young-Hwan Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.